Acura Pharmaceuticals Inc: Acura Pharmaceuticals : Termination of Material Agreement - Form 8-K

(marketscreener.com) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act Of 1934 Date of Report : August 14, 2023 ...https://www.marketscreener.com/quote/stock/ACURA-PHARMACEUTICALS-IN-120789192/news/Acura-Pharmaceuticals-Termination-of-Material-Agreement-Form-8-K-44630204/?utm_medium=RSS&utm_content=20230816